Lakshmi Prasanna Kolluru
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Lakshmi Prasanna Kolluru has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- Prachi Atre
College of Pharmacy and Health Sciences, St. John’s University, Queens, NY 11439, USA
1 shared publication - • Syed A. A. Rizvi
College of Biomedical Sciences, Larkin University, Miami, FL 33169, USA
1 shared publication
Latest Publications
- Open Access
- 29 January 2021
- Published by MDPI AG in Pharmaceuticals
- Vol. 14 (2) , 108
Characterization and Applications of Colloidal Systems as Versatile Drug Delivery Carriers for Parenteral Formulations
Preparing a suitable formulation for parenteral administration is already a difficult task; this, coupled with poor water-soluble new chemical entity (NCE), complicates this situation even further. There are several methodologies available to enhance water solubility, but this alone does not entail successful formulation. Making a micro/nano emulsion with a suitable surfactant not only increases the drug solubility but also the cell membrane permeability. Thus, not only biopharmaceutic classification system (BCS)-II (low solubility compounds) but also BCS-III (low permeability) and BCS-IV drugs (low solubility and low permeability) can be further exploited. Those drug candidates otherwise will not move further in NCE evaluation or clinical trials. This succinct review article delves into various aspects of biphasic micro/nano emulsion systems for parenteral drug delivery including the structure of the biphasic colloidal systems, characterization parameters, stability issues, regulatory considerations, and applications in life sciences.
- 29 January 2021
- Published by MDPI AG in Pharmaceuticals
- Vol. 14 (2) , 108
Open AccessCharacterization and Applications of Colloidal Systems as Versatile Drug Delivery Carriers for Parenteral Formulations
Preparing a suitable formulation for parenteral administration is already a difficult task; this, coupled with poor water-soluble new chemical entity (NCE), complicates this situation even further. There are several methodologies available to enhance water solubility, but this alone does not entail successful formulation. Making a micro/nano emulsion with a suitable surfactant not only increases the drug solubility but also the cell membrane permeability. Thus, not only biopharmaceutic classification system (BCS)-II (low solubility compounds) but also BCS-III (low permeability) and BCS-IV drugs (low solubility and low permeability) can be further exploited. Those drug candidates otherwise will not move further in NCE evaluation or clinical trials. This succinct review article delves into various aspects of biphasic micro/nano emulsion systems for parenteral drug delivery including the structure of the biphasic colloidal systems, characterization parameters, stability issues, regulatory considerations, and applications in life sciences.